SK&F106615
Term · Oncology and biomedicine · MLC-T-ONC-007797
A substance being studied in the treatment of certain multiple myelomas and other advanced cancers. SK&F106615 may block the growth of tumors and may prevent the growth of new blood vessels that tumors need to grow. SK&F106615 is a type of signal transduction inhibitor and a type of antiangiogenesis agent. Also called atiprimod and azaspirane.
| Identifier | MLC-T-ONC-007797 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | atiprimod; azaspirane |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007797",
"term": "SK&F106615",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of certain multiple myelomas and other advanced cancers. SK&F106615 may block the growth of tumors and may prevent the growth of new blood vessels that tumors need to grow. SK&F106615 is a type of signal transduction inhibitor and a type of antiangiogenesis agent. Also called atiprimod and azaspirane.",
"expansions": [
"atiprimod",
"azaspirane"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/sk-and-f106615/"
}
Record 15,054 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.